| Avanir's Zenvia 12-week Extension Study Reports Sustained... |
|
(RTTNews) - Tuesday, Avanir Pharmaceuticals, Inc. (AVNR: News ) said a low dose formulation of its investigational drug Zenvia was found to provide statistically significant... More »
|
|
RTTNews.com - Nov. 10, 2009
|
| Avanir Pharma: Neurological Drug Meets Goal In Extended... |
|
DOW JONES NEWSWIRES Avanir Pharmaceuticals Inc.(AVNR) said the new low-dose version of neurological disorder pill Zenvia reduced the frequency and severity of uncontrollable... More »
|
|
Morningstar.com - Nov. 10, 2009
|
| UPDATE 1-Avanir posts positive Zenvia data, shares rise |
|
* Shares rise 11 pct Nov 10 (Reuters) - Avanir Pharmaceuticals Inc said final data from a late-stage trial of its experimental neurological disorder drug showed that it was... More »
|
|
Interactive Investor International - Nov. 10, 2009
|
| Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy... |
|
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase... More »
|
|
Genetic Engineering News - Nov. 10, 2009
|
| UPDATE 1-Avanir posts positive Zenvia data, shares rise |
|
* Final data shows drug safe, effective and well tolerated * Shares rise 11 pct Nov 10 (Reuters) - Avanir Pharmaceuticals Inc (AVNR.O) said final data from a late-stage trial... More »
|
|
Reuters - Nov. 10, 2009
|
| BRIEF-Avanir announces neurological disorder trial data |
|
Nov 10 (Reuters) - Avanir Pharmaceuticals Inc (Delaware): * Announces zenvia safety and efficacy data from star trial open label extension * Says patients maintained on... More »
|
|
Forbes.com - Nov. 10, 2009
|
| UPDATE 1-Avanir posts positive Zenvia data, shares rise |
|
* Final data shows drug safe, effective and well tolerated * Shares rise 11 pct Nov 10 (Reuters) - Avanir Pharmaceuticals The drug, Zenvia, treats pseudobulbar affect (PBA),... More »
|
|
Forbes.com - Nov. 10, 2009
|
| Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy... |
|
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR - News) today announced efficacy, safety and tolerability results from the 12-week open-label... More »
|
|
Business Wire via Yahoo! - Nov. 10, 2009
|
| Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy... |
|
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase... More »
|
|
Individual.com - Nov. 10, 2009
|
| Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy... |
|
Author : AVANIR Pharmaceuticals, Inc. Category : Press Release News Alerts by Email ( click here ) News | Home ALISO VIEJO, Calif. - (Business Wire) AVANIR Pharmaceuticals,... More »
|
|
Earthtimes.org - Nov. 10, 2009
|